| |
|
|
| Chief Executive Officer, Chief Financial Officer, Controller, Vice President Business Development |
| President Diabetes Care |
| U.S. Therapeutic Unit Head |
| Chief Medical Officer |
| Medical Director, Clinical Development |
| Competitor Assessment |
|
|
| HPI was retained to build the senior management team of this recently funded biotechnology company focusing on therapeutics for age-related macular degeneration. (AMD) |
| The Diabetes Care Division is one of the world's market leaders in self test blood glucose diagnostics systems. This Division was recently created and required an experienced executive to lead the business. HPI was retained to recruit the new leader |
| The U.S. Pharmaceutical Division required an experienced commerical executive to hold P&L responsibility and lead the development of strategy and execution of marketing plans for the branded respiratory pharmaceutical business. |
| HPI was retained by the Pharmaceutical Division to identify a CMO to lead the drug development efforts of several lead compounds in the areas of CNS and Oncology. |
| The U.S. Pharmaceutical Division required a Medical Director to lead their effort to develop a new therapeutic for women's health. |
| HPI has been retained to provide competitor benchmarking feedback for this leading vaccine company. |
|
 |
